ABSTRACT

Background:

Hair loss is a common clinical presentation in any medical clinic. Telogen effluvium is considered among the most prevalent causes of hair loss particularly in female patients. Telogen effluvium may associate with significant psychosocial comorbidities and the medical treatment may be challenging. In this article we will review the recent literatures about epidemiology, etiopathogenesis, clinical presentation and management of telogen effluvium.

Method:

An electronic literature search was performed using the PubMed and Google Scholar to identify relevant articles published between 1993 and 2017. Search keywords included “telogen effluvium” and “hair loss”. We included studies published in English. Editorials, brief notes, conference proceedings, and letters to editors were excluded.